Mar 28 |
Fulcrum Therapeutics to Participate at the Cantor Virtual Muscular Dystrophy Symposium
|
Mar 18 |
Fulcrum Therapeutics appoints Patrick Horn as permanent Chief Medical Officer
|
Mar 18 |
Fulcrum Therapeutics Appoints Patrick Horn M.D., Ph.D., as Chief Medical Officer
|
Mar 7 |
CEO, President & Director of Fulcrum Therapeutics Alexander Sapir Buys More Stock
|
Mar 6 |
Fulcrum hits 52-week high as CEO buys shares
|
Mar 5 |
Fulcrum Therapeutics to Participate at the Leerink Partners Global Biopharma Conference
|
Feb 28 |
Fulcrum Therapeutics Full Year 2023 Earnings: Beats Expectations
|
Feb 28 |
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2023 Earnings Call Transcript
|
Feb 28 |
Q4 2023 Fulcrum Therapeutics Inc Earnings Call
|
Feb 27 |
Fulcrum Therapeutics files for $350M mixed shelf
|